Biohaven Ltd. stock is up 19.77% since 30 days ago. The next earnings date is Mar 21, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 42.86% of the previous 6 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 9 CALLs, 1 PUT. 100% of analysts rate it a buy.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
17 Oct 18:56 | 17 Nov, 2023 | 30.00 | 291 | ||
18 Oct 13:57 | 20 Oct, 2023 | 20.00 | 760 | ||
18 Oct 13:58 | 20 Oct, 2023 | 22.50 | 751 | ||
19 Oct 15:26 | 20 Oct, 2023 | 17.50 | 148 | ||
24 Oct 18:37 | 17 Nov, 2023 | 30.00 | 551 | ||
25 Oct 14:50 | 15 Dec, 2023 | 30.00 | 100 | ||
13 Nov 19:51 | 19 Jan, 2024 | 25.00 | 360 | ||
27 Nov 16:36 | 19 Jan, 2024 | 25.00 | 704 | ||
28 Nov 15:16 | 19 Jan, 2024 | 25.00 | 709 | ||
08 Dec 15:01 | 19 Jan, 2024 | 35.00 | 817 |
Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.